Detection assay of polymyxin resistance coding mcr-1 gene based on CRISPR/Cas13a system
Frontiers in Cellular and Infection Microbiology · 2025
DOI: 10.3389/fcimb.2025.1553681 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Yingjie Song und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, Beijing, China. Hauptthemen laut MEDLINE: CRISPR-Cas Systems, Escherichia coli Proteins, Polymyxins, Escherichia coli. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China.
Abstract (Originalsprache)
Introduction
Polymyxins are reserved as an ultimate defense against multidrug-resistant bacteria. The emergence of the polymyxin resistance gene mcr-1 poses a potential risk for the treatment of severe infections caused by Gram-negative bacteria. Timely detection and monitoring the mcr-1 gene are essential for guiding anti-infective therapy and controlling the spread of polymyxin resistance. Quantitative real-time PCR (qPCR) is one of the common methods for detecting resistance genes. However, qPCR has equipment dependency, and is not feasible in primary healthcare settings. Currently, there remains a lack of a highly sensitive and portable method for detecting the mcr-1 gene.
Methods
We established and optimized detection assays of the mcr-1 gene based on CRISPR/Cas13a system and lateral flow strips. The detection method was preliminarily evaluated using clinical isolates from Escherichia coli , compared with qPCR.
Results
The method for detecting the mcr-1 gene based on the CRISPR/Cas13a system and lateral flow strips was established, with a detection limit of 100 copies/mL. This method demonstrated high analytical specificity, with no cross-reactivity detected in non- mcr-1 and non-resistant strains. Among 36 clinical isolates, the method identified 31 strains as positive for the mcr-1 gene, and had a 100% concordance rate with the results of qPCR.
Conclusions
We established a detection method for the polymyxin resistance mcr-1 gene based on the CRISPR/Cas13a system. This method enables visual readouts without instruments, making it potentially applicable to primary healthcare settings and field surveillance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, Beijing, China.
- Chinese PLA Center for Disease Control and Prevention, Beijing, China.
Förderung
- National Key Research and Development Program of China
Zitieren
APA
Song, Y., Hu, Q., Han, Y., Liu, H., Huang, Z., Niu, M., Dong, X., Yan, K., Jin, L., Li, H., & Sun, Y. (2025). Detection assay of polymyxin resistance coding mcr-1 gene based on CRISPR/Cas13a system. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1553681
Vancouver
Song Y, Hu Q, Han Y, Liu H, Huang Z, Niu M, et al. Detection assay of polymyxin resistance coding mcr-1 gene based on CRISPR/Cas13a system. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1553681
BibTeX
@article{Song2025,
author = {Song, Yingjie and Hu, Qiang and Han, Yao and Liu, Hongbo and Huang, Zhenyang and Niu, Mengwei and Dong, Xue and Yan, Kuocheng and Jin, Li and Li, Hao and Sun, Yansong},
title = {Detection assay of polymyxin resistance coding mcr-1 gene based on CRISPR/Cas13a system},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2025},
doi = {10.3389/fcimb.2025.1553681}
}
EUVIMED